Understanding Prostate Biopsy & MRI-Fusion Biopsy
When a biopsy is the right call, the two routes a urologist can take, what the MRI changes, and how to read your result. Written in plain language for adults.
Welcome
If you have been told you may need a prostate biopsy, you probably have questions. A lot has changed in how this test gets done, and this guide walks through it before your appointment.
This guide picks up where the elevated-PSA guide leaves off. If you have not yet been through the workup that brought you here, that guide explains how a PSA, an exam, and an MRI lead to the biopsy decision. If your biopsy already shows cancer, the localized prostate cancer guide picks up there.
How to use this guide. If you are deciding whether to have the biopsy at all, start with Chapter 2. If your biopsy is already scheduled, jump to Chapter 4 (the two routes) and Chapter 6 (what to expect on the day). If your result is back and you are looking for what the pathology terms mean, go to Chapter 9.
What a prostate biopsy is
A prostate biopsy removes a few small cores of tissue from the prostate so a pathologist can look for cancer under a microscope. Your PSA, exam, and MRI can only estimate the chance of cancer. The tissue shows what is actually there.
What the biopsy adds
Your PSA blood level, your exam, your family history, and your prostate MRI all estimate how likely prostate cancer is. The biopsy shows what cells are actually in your prostate. If cancer is there, it also shows how aggressive the cells look.
Even after the result comes back, your urologist puts it together with your PSA, MRI, prostate size, exam, and sometimes a genomic test to set the plan.
A biopsy is a diagnostic test, not a treatment. It is done when the chance of finding meaningful cancer is high enough that the result would change what you do next.
When biopsy is the right call
A prostate biopsy is a diagnostic test rather than a routine screen. It is done when several findings line up, and you and your urologist decide together whether to go ahead.
The usual paths to a biopsy
Most men reach the biopsy decision after one of four paths. Sometimes more than one applies.
- A persistently elevated or rising PSA. One borderline value rarely sends you to biopsy. A pattern of rising values over time, or a single very high value, does.
- An abnormal rectal exam. A firm area, a lump, or a clear difference between the two sides of the prostate can raise the chance of cancer even when the PSA is not high.
- A worrisome prostate MRI. A lesion scored 3 or higher on the MRI's Prostate Imaging Reporting and Data System (PI-RADS) scale. The biopsy then aims the needle at the lesion.
- A prior negative biopsy with ongoing concern. A rising PSA, a new MRI lesion, or a finding of "atypia" on a past biopsy can lead to a repeat biopsy.
When the bar is higher
Some men need more evidence before a biopsy makes sense. Your urologist may add a blood or urine test called a biomarker to sharpen the picture. A good biomarker result and a clean MRI can put off a biopsy in many men with a mildly raised PSA.
When the bar is lower
Some men have a higher risk of meaningful cancer at any given PSA. That includes men with a strong family history of prostate cancer, men with a known BRCA or Lynch mutation, and Black men. For those men, your urologist may move to biopsy at a lower PSA.
A biopsy that is done too readily can find low-grade cancers that may never have caused harm, which can lead to over-treatment. A biopsy that is deferred too long can miss a treatable cancer.
The MRI step before biopsy
A prostate MRI is the biggest change in prostate cancer testing in the past ten years. At most major centers in 2026, the MRI is done first, and the biopsy is shaped by what the MRI shows.
What the MRI does
A prostate MRI uses several imaging methods at once to look for any suspicious area inside the prostate. A trained radiologist reads the scan. They score any suspicious area on a 1 to 5 scale called PI-RADS. The score is their best read on how likely it is that meaningful cancer is in that area.
What the PI-RADS score means
- PI-RADS 1 or 2. Low suspicion. Many men with a mildly elevated PSA and a reassuring biomarker can defer a biopsy and stay on a PSA watch. This does not promise that no cancer exists. It means the chance of missing a meaningful cancer is low enough to wait.
- PI-RADS 3. The gray zone. Your urologist weighs PSA density, family history, and biomarker results to decide. Some men go to biopsy. Others go to closer follow-up.
- PI-RADS 4 or 5. Higher suspicion. A biopsy is usually recommended, with the needle aimed at the MRI lesion.
What the MRI cannot do
The MRI does not replace the biopsy when one is needed. It decides where the needle goes. A negative MRI lowers the chance of meaningful cancer but does not bring it to zero, especially in men with a high PSA density, a strong family history, or a BRCA mutation. A small share of clinically important cancers are missed even on a good read.
Reading prostate MRI well takes special training, and reads are best at high-volume centers. Insurance coverage for pre-biopsy MRI has improved but is not universal. If you can choose where to have the scan, pick a center that reads many of these each week.
The two routes: transperineal and transrectal
There are two main ways the biopsy needle can reach your prostate. They differ in the path the needle takes, the infection risk, and the anesthesia setup. Cancer detection is similar in head-to-head studies.
The transrectal route
The needle passes through the wall of the rectum into the prostate, guided by ultrasound. This is the route urologists have used for decades. It is usually done in the office with a numbing shot. Antibiotics are given before the biopsy to lower the chance of infection. Some practices add a rectal swab first to find resistant bacteria and pick the right antibiotic.
The transperineal route
The needle passes through the skin between the scrotum and the anus into the prostate. That patch of skin is called the perineum. The ultrasound probe still goes in the rectum, but the needle does not cross the rectal wall. Because the needle does not pass through gut bacteria, the infection rate is much lower. Office-based transperineal biopsy with a numbing shot is more and more common at academic centers and many high-volume community practices.
Side by side
| Transperineal | Transrectal | |
|---|---|---|
| Needle path | Through the skin between the scrotum and the anus. | Through the wall of the rectum. |
| Infection rate | Less than 0.5 percent. | About 1 to 3 percent with modern antibiotic prep. |
| Antibiotics | Often none, or a single dose. | Standard before the procedure. Sometimes guided by a rectal swab. |
| Anesthesia | Local, sometimes light sedation. General anesthesia in some practices. | Local, with a numbing shot around the prostate. |
| Rectal prep | Usually not needed. | Enema in some practices, none in others. |
| Cancer detection | Similar. | Similar. |
Which route is right for you
Both routes can diagnose cancer well. Transperineal biopsy does have a lower infection rate, and that is the main reason many practices have moved to it as the default. A urologist who does transrectal biopsy with careful antibiotic prep is still working well within the standard of care.
The right choice depends on what your urologist does most often, what your center is set up for, your prior infection history, and your prostate shape and size. Ask which route your practice offers and why.
If your practice offers transrectal biopsy, ask what their infection rate has been over the past year. Ask what antibiotic plan they use. If your practice offers transperineal biopsy, ask whether it is done in the office with a numbing shot or in a procedure room with sedation.
MRI-fusion: targeted plus systematic
When an MRI lesion is present, modern practice takes two kinds of cores. Targeted cores aim at the lesion, and systematic cores sample standard zones across the gland. Each set finds cancer the other can miss.
Why both sets of cores
The targeted cores aim the needle at the spot the MRI flagged. They are the highest-yield cores for finding the cancer the MRI saw. Systematic cores sample 10 to 14 standard zones of the prostate in a set pattern. They are how urologists find cancer that the MRI did not see, because cancer can sit outside the visible lesion.
In large studies, the combined approach finds more meaningful cancer than either set of cores alone. The exact numbers vary by study.
How the targeting works
There are a few ways to aim a biopsy needle at an MRI lesion.
- Cognitive fusion. Your urologist studies the MRI before the biopsy. They use the picture in their head as a map during the ultrasound-guided biopsy. No special equipment.
- Software fusion. A computer lines up the MRI images with the live ultrasound and shows the lesion on the screen during the biopsy. The needle position is tracked against the lesion.
- In-bore MRI biopsy. The biopsy is done inside the MRI scanner itself, with the needle aimed directly at the lesion on the live MRI. Less common and saved for specific situations.
All three approaches work. Software fusion is the most common at centers that do many of these. Cognitive fusion is fine for clear, large lesions and is the simplest setup. The result of the biopsy depends more on the quality of the MRI read and the urologist's experience than on which fusion method was used.
If your urologist has called it a fusion biopsy, the plan is to take targeted cores from the lesion and systematic cores from the rest of the prostate in one visit. You should not have to come back twice.
What to expect on the day
An office prostate biopsy takes about 20 to 30 minutes once it starts. Most men go home the same day with no anesthesia hangover and a few simple instructions.
Before you arrive
- Eat a light meal unless told otherwise.
- Take your routine medications. Do not stop blood thinners on your own. Your team will tell you what to hold and what to keep.
- Bring a list of your current pills, any drug allergies, and any past infections.
- If you were given an antibiotic, take it on the schedule your team gave you.
- Arrange a ride home if you are having sedation.
The procedure itself
The team will confirm the plan with you. You will be positioned on your side for a transrectal biopsy, or on your back with your legs in stirrups for a transperineal biopsy.
A numbing shot is given around the prostate for either route. Transperineal biopsies also have numbing of the skin where the needle goes in. The numbing takes a few minutes to work.
An ultrasound probe in the rectum gives the urologist a live picture of the prostate. The biopsy gun is a thin, spring-loaded device. Each time it fires, it makes a sharp clicking sound and takes a small core in less than a second. Most biopsies take 10 to 14 systematic cores, plus any targeted cores from an MRI lesion. Some urologists take more cores than others. The number varies from one doctor and one center to the next.
What you will feel
Most men feel pressure and some brief sharpness with each core. The numbing shot handles most of the discomfort. The clicking sound of the biopsy gun is loud and can startle you on the first core, which is why a good team warns you first.
Right after
You will rest for a short time in the office. Most men walk out within 30 minutes. You can drive yourself home if you did not have sedation. You will be given written instructions and a phone number to call if anything worries you in the first week.
Risks of a prostate biopsy
A prostate biopsy is safe for most men. Infection is the risk that matters most. The other problems below are usually minor and settle on their own.
Infection
Infection after a biopsy is uncommon, and it happens more often after the transrectal route than the transperineal route. With careful antibiotic prep, the chance of a serious infection after transrectal biopsy is about 1 to 3 percent. After transperineal biopsy it is less than 0.5 percent. The worst form, sepsis, is rare but can be life-threatening when it happens. If you run a fever or get shaking chills after a biopsy, call the same day.
Bleeding
Some light bleeding is expected after a biopsy. You may see a small amount of blood in your urine for a few days, a small amount in your stool for a day or two after transrectal biopsy, and blood in your semen for several weeks. If you see heavy bright red bleeding with clots, or bleeding that soaks through pads, call the office or go to the ER.
Trouble urinating
Some men have a hard time starting their stream for a day or two after biopsy because of swelling. A few men cannot urinate at all, called urinary retention. That happens to about 1 to 2 out of 100 men and is more likely if your prostate was already large and your stream was already slow before the biopsy. Retention is treated with a catheter for a short time and then a follow-up plan.
Pain and soreness
Mild soreness in the rectum or perineum is normal for 1 to 3 days. Acetaminophen helps. If your pain is severe and getting worse, call the office.
A false-negative result
A biopsy can miss cancer that is there. The combined targeted plus systematic approach lowers this risk but does not remove it completely. If your PSA keeps rising or your MRI changes after a negative biopsy, your urologist may recommend a repeat biopsy later. A repeat biopsy is a normal part of follow-up.
You run a fever over 100.4 degrees Fahrenheit, get shaking chills, or feel shaky and unwell. You cannot urinate at all. Your bleeding from the rectum or in the urine has clots and will not stop. Your pelvic pain is severe and getting worse. You feel dizzy, faint, or very weak. A fever after biopsy can be a medical emergency.
Recovery, week by week
Most men go back to normal life within a few days of the biopsy. Blood in semen is the side effect that lasts the longest.
The first 24 to 48 hours
- Take it easy. No heavy lifting, no vigorous exercise, no bike riding.
- Drink fluids unless you have been told otherwise. Fluid helps clear small amounts of blood from the urine.
- If you were given an antibiotic, finish the whole course on schedule.
- Use acetaminophen for soreness. Some practices ask you to avoid ibuprofen for the first 24 hours because it can raise bleeding risk. Follow the plan you were given.
- Watch for fever, heavy bleeding, or trouble urinating. The numbers and the trigger to call are in Chapter 7.
Days 2 to 7
- Most men return to desk work the next day or the day after.
- Light walking and normal household activity are fine.
- Hold off on heavy lifting, vigorous exercise, and bike riding for about a week.
- Sex is usually fine after a few days. Blood in semen is normal and not harmful to a partner.
Weeks 2 to 6
- Blood in semen can last about 6 weeks. It can look dark brown, rust-colored, or red. This is normal and not harmful.
- Mild soreness fades within the first week.
- Your pathology result usually comes back about a week after the biopsy. Some practices call you with the result. Others schedule an in-person visit to review it.
- If you take aspirin or a blood thinner that was held for the biopsy, restart on the schedule your team gave you. Do not restart on your own.
If your result is benign, the next step is usually a follow-up PSA and exam. If the result shows cancer, the next conversation is about Grade Group, risk group, and treatment options. Chapter 9 covers what those terms mean.
Understanding your result
The pathology report comes back about a week after the biopsy. It uses a set of specific words to describe what the pathologist saw under the microscope.
Benign prostate tissue
No cancer was found. The next step is usually a PSA and exam follow-up on a schedule that matches your risk. A negative biopsy lowers the chance of cancer without ruling it out. Your urologist will set the timing for the next PSA, the next exam, and whether or when to repeat the MRI.
Inflammation or prostatitis
Inflammation of the prostate. It can raise the PSA by itself, and it can hide a cancer or be confused for one. If symptoms are present, treatment of the inflammation may come first, with a repeat PSA later.
HGPIN (high-grade prostatic intraepithelial neoplasia)
Not cancer. A change in the cells lining the prostate ducts that looks like a precursor. It slightly raises the chance of finding cancer on a later biopsy. The usual response is closer PSA follow-up, not an automatic repeat biopsy.
ASAP (atypical small acinar proliferation)
Cells that look odd but are not clearly cancer. Most urologists recommend a repeat biopsy within 6 to 12 months, with an MRI ahead of it if you have not had one.
Prostate cancer
If cancer is found, the report names a Grade Group and a Gleason score. It also lists how many cores had cancer, how much of each core was involved, and other features your urologist will explain.
- Grade Group 1. Low-grade cancer. Often watched with active surveillance, not treated. Most men with this finding live a normal lifespan with the cancer in place.
- Grade Group 2. Favorable intermediate-risk in most cases. Some men are still candidates for active surveillance if the volume is low. Others move to treatment.
- Grade Group 3. Unfavorable intermediate-risk. Treatment is usually recommended.
- Grade Group 4. High-grade cancer. Treatment is recommended.
- Grade Group 5. The highest grade. Active treatment is recommended, with a closer staging workup to follow.
The biopsy result is one piece of the picture. PSA, MRI, prostate size, exam, sometimes a genomic test, and sometimes additional imaging all combine with the biopsy to set the risk group. The localized prostate cancer guide walks through risk groups and treatment options in plain language.
A cancer on biopsy does not mean a same-week surgery or radiation visit. For many men with low-grade cancer, active surveillance is a well-studied plan. Read the next guide, then talk it through with your urologist.
Questions to ask your urologist
Print this page or pull it up on your phone in the office.
- Based on my PSA, exam, and MRI, what is your best estimate of the chance my biopsy will show meaningful cancer?
- Which route are you planning, transperineal or transrectal, and why?
- What is your practice's infection rate over the past year, and what is the antibiotic plan for me?
- How many cores are you planning, and how many will be targeted at the MRI lesion if I have one?
- Will I be on local anesthesia, sedation, or general anesthesia? Do I need a ride home?
- Which of my medications should I hold before the biopsy, and when do I restart them?
- When and how will my result come back, and what is the next step depending on what it shows?
- If my result is "atypia" or HGPIN, what is your plan?
Words to know
These are the terms a urologist will use during your biopsy visit and on your pathology report.
- PSA (prostate-specific antigen)
- A protein made by the prostate that shows up in the blood. The level helps estimate the chance of cancer, along with your exam, your family history, and an MRI.
- Digital rectal exam (DRE)
- A finger exam through the rectum to feel the prostate. A firm area or a nodule on this exam can raise the chance of cancer at any PSA.
- Multiparametric prostate MRI
- A prostate scan that combines several imaging methods to look for suspicious areas. The modern step before a biopsy in most major centers.
- PI-RADS
- A 1 to 5 scale a radiologist uses to score how suspicious an MRI finding is. 1 to 2 is low. 3 is uncertain. 4 to 5 is higher suspicion.
- MRI-fusion biopsy
- A biopsy that uses the MRI images alongside live ultrasound so the needle can be aimed at MRI-visible lesions.
- Targeted core
- A biopsy core aimed at a lesion seen on MRI.
- Systematic core
- A biopsy core taken from a standard zone of the prostate, regardless of what the MRI showed.
- Transperineal biopsy
- A biopsy route through the skin between the scrotum and the anus. Lower infection rate.
- Transrectal biopsy
- A biopsy route through the rectal wall. Still widely used.
- Gleason score
- The pathologist's grading system for prostate cancer aggressiveness. Two numbers that add up to a total from 6 to 10.
- Grade Group
- A simpler 1 to 5 scale based on the Gleason score. Grade Group 1 is the least aggressive. Grade Group 5 is the most aggressive.
- HGPIN
- High-grade prostatic intraepithelial neoplasia. A precursor-looking change that is not cancer.
- ASAP
- Atypical small acinar proliferation. Cells that are not clearly cancer but are suspicious enough to repeat the biopsy.
- Perineural invasion
- Cancer cells found around a nerve in the biopsy core.
- Cribriform pattern
- A specific cancer architecture under the microscope that raises the chance of more aggressive behavior.
Sources and further reading
This guide is built on the urology research and the standard sources listed here, current through 2026.
- EAU Guidelines on Prostate Cancer, 2025. Diagnostic evaluation and MRI-targeted biopsy sections. uroweb.org
- EAU Guidelines on Urological Infections, 2025. Prostate biopsy infection-prevention sections. uroweb.org
- PRECISION trial (Kasivisvanathan et al., NEJM 2018; NCT02380027). MRI-targeted or standard biopsy for prostate-cancer diagnosis. nejm.org
- PROMIS study (Ahmed et al., Lancet 2017). Diagnostic accuracy of multiparametric MRI and TRUS biopsy. pubmed.ncbi.nlm.nih.gov
- Local anesthesia transperineal prostate biopsy. Stabile et al., European Urology Oncology, 2020. pubmed.ncbi.nlm.nih.gov
- Transperineal versus transrectal prostate biopsy, infection comparison. Pradere et al., systematic review and meta-analysis. pubmed.ncbi.nlm.nih.gov
- ISUP 2014 modified Gleason / Grade Group consensus. Epstein et al., American Journal of Surgical Pathology. pubmed.ncbi.nlm.nih.gov
- WHO Classification of Tumours: Urinary and Male Genital Tumours, 5th edition, 2022. Prostate tumour classification. publications.iarc.fr
- NCCN Guidelines for Patients: Prostate Cancer Early Detection, 2026. Patient-facing summary. nccn.org/patients
- National Cancer Institute. Prostate cancer screening (PDQ) for patients. cancer.gov
About this guide. Written by the WellPrept Clinical Team. Always talk through your own case with your urologist.